Target intelligence / Profile preview

AT-hook DNA binding motif containing 1 (AHDC1)

Target
AHDC1
Molecular classification
Transcription factor, Chromatin modifier, DNA-binding protein, Nuclear protein
01

Overview

AHDC1 is a nuclear protein distinguished by its two AT-hook DNA-binding motifs, which facilitate its association with AT-rich DNA regions[1][4]. The AT-hook domain allows binding to the minor groove of DNA, altering chromatin architecture and influencing transcription[3][6]. AHDC1 participates in the regulation of gene expression during development, particularly in patterning the epidermis and epithelial morphogenesis[7]. Mutations—especially truncating or missense variants—lead to Xia-Gibbs syndrome, characterized by developmental delay, intellectual disability, hypotonia, sleep disturbances, limited speech, and distinct dysmorphic features[1][4][7]. AHDC1 is also reported to influence tumor progression in cancer contexts via regulatory RNA networks[4]. There is so far no evidence of direct drug interactions, and it is not considered a conventional therapeutic target, but its mutation status serves as a genetic biomarker for certain syndromic diseases[1][4][7].

Other names
AHDC1MRD25Transcription factor GibbinDJ159A19.3RP1-159A19.1XIGISAT-hook DNA-binding motif-containing protein 1transcription factor Gibbin
02

Biological functions

Transcriptional regulationChromatin architecture organizationDNA binding
03

Disease associations

Neurodevelopmental disorders (Xia-Gibbs syndrome, developmental delay, intellectual disability, autism spectrum disorder, hypotonia, sleep apnea)Cancer (implicated in cervical cancer progression)
04

Safety considerations

Mutations lead to severe developmental delay, neurodevelopmental disorders, and other congenital syndromesNo drug-based safety or toxicity issues described
05

Biomarkers

AHDC1 gene mutation (used for diagnosis of Xia-Gibbs syndrome and related neurodevelopmental disorders)

Beyond the preview

Go deeper on AT-hook DNA binding motif containing 1 (AHDC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AT-hook DNA binding motif containing 1 (AHDC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call